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A Fresh Look at Augmenter of Liver Regeneration In Rats 
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MICHAEL A. NALESNIK, SIMON C. WATKINS, ALBERT DELEO, MASSIMO TRUCCO, AND THOMAS E. STARZL 
Augmenter of liver regeneration (ALR) is a hepatottophic 
protein originally identified by bioassay in regenetatingrat 
and canine livers following partial hepatectomy and in the 
hyperplastic livers of weanling rats, but not in testing adult 
livers. The ALR gene and gene product w~re ~ubseque:r1tly 
described, but little is known about the cellular/subcellular 
sites of ALR synthesis in the liver, or about the release and 
dissemination of the peptide. To obtain this information in 
rats, .we raised antibodies in rabbits against rat ALR for 
development of an enzyme-linked immunosorbent assay 
(ELISA). ALR concentrations were then determined in intact 
livers of unaltered weanling and adult rats; in regenerating 
residual liver after partial hepatectomy; in cultured hepato-
cytes and nonparenchymal cells (NPCs); and in cultnremedium 
and serum. ALR in the various liver cells Was localized with 
immunohistochemistry. In addition, hepatic ALRand ALR 
mRNA were as'sayed with Western blotting and reverse~ 
transcriptase polymera~e chain reacHon (RT-peR), respec-
tively. The hepatocyte was the predominant liver cell in 
which ALR waS . synthesized and stored;' t.h,e cultured 
hepatocytes s~creted ALR into the medium in a time-
dependent fashiori.· Contrary to previous belid, the ALR 
peptide and ALR niRNA were present in comparable concen-
trations in the hepatocytes of both weanling and reSting 
adult livers, as well' as in cultured hepatocytes. A further 
unexpected finding was that hepatic ALR levels decreas~d 
for 12 hours after 70% hepatectomy in adult rats and then 
rose with no corresponding change inmRNA transcripts. In 
the meantime, circulating (serum) ALR levels increased up 
to 12 hours and declined thereafter. Thus, ALR appears to 
be constitutively expressed in hepatocytes in an inactive 
form, and released from the cells in an active form by 
unknown means in response to partial hepatectomy and 
under other circumstances of liver maturation (as in wean-
ling ratS) or regeneration. (HEPATOLOGY 1999;O9:14PR~ 
1445.) 
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The control of hepatic growth and regeneration has inter-
ested experimentalists for much of the 20th century.l Soon 
after the ciassical description in 1931 by l:Iiggins and Ander-
son2 of liver regeneration in rats followiJ:lg 70% hepatectomy, 
a search began for growth factors within the liver itself. 
Mcjunkin and Breuhaus3 observed that the modest mitotic 
response to a 30% to 40% hepatectomy in rats was enhanced 
with an intraperitoneal injection 2 days postoperatively of 
homogenized homologous rat liver. Iwo decades later, Teir 
and Ravanti4 and BioniqUist5 noted that this "augmentation" 
effect was demonstrable only when the injected homogenates 
were prepared from regenerating liver fragments folloWing 
hepatectomy or from weanling rat livers that have a naturally 
heighteneclmitotic index. Subsequently, LaBrecque and Pesch6 
reported the same prerequisite of a hyperplastic liver source 
for cytosol extracts containing a putative "hepatic stimulatory 
substance" (HSS). . 
'. Importantly, however, a co condition for demonstrating a 
mitosis-augmeriting activity of cytosolic HSS6 was its injec-
tion into test rats whose livers already were primed, I.e., 
. committed to an increased mitotic response induced by 
partial hepatectomy. Consequently, LaBrecque and Pesch 
standardized the minimum (40%) hepatectomy assay for 
HSS, a modification of which has been used to study HSS in 
dogs. 7 The assay also has been used increasingly to study 
other hepatic growth factors whose in vivo role in regenera-
tion has been largely extrapolated from results with in vitro 
models.s-u The principal limitation of this assay is the 
variability of the mitotic response to the priming hepatec-
tomy, and the additional variability of the mitosis augmenta-
tion,1,s 
The far more sensitive canine Eck fistula assay that 
ultimately guided the steps in purification of HSS8 also is 
based on the priming principle, because portacaval shunt 
causes a tripling of hepatic cell renewal,lH5 In essence, this 
assay consists of performing a completelYdi.verting portaca-
val~hunt in dogs, and theninfusing test substances into one 
of the detached main portal vein branches while simply 
ligating' the other main branch, and then comparing the 
infused liver lobes With the noninfused (control) lobes. In 
1975, it was demonstrated that a nonhypogly<;:emic infusion 
of insulin prevented the characteristic hepatocyte atrophy 
and organelle disruption caused by the portal diversion. In 
addition, the already-heightened rate of hepatocyte mitosis 
was quadrupled. l4,l5 Combined with previous evidence from 
a variety of experimental modeis,:t6-22. it now had been 
established that portal venous blood contained factors, domi-
naled by but not limited to insulin, that were essential for the 
maintenance of normal liver size, function, and the capacity 
for regeneration. . 
1435 
1436 GANDHI ET AL 
The spectacular augmentation of the mitotic response 
caused by insulin in the Eck fistula model14;l5 was consistent 
with earlier observations of Younger, King, and Steiner23 in 
rats that were allowed to be alloxan-diabetic for 1 month 
before treating them with insulin. The livers of the diabetic 
rats already contained an abnormally high number of hepato-
cy~esI but as in the hyperplastic Eck fistula livers, the 
proliferative response to insulin was as great as that following 
a 40% to 50% hepatectomy The insulin effects were so 
,overwhelming that despite circumstantial evidence of weaker 
but cumulatively' important additional splanchnic growth 
factors,15,20-22 no other growth factors exclusively secreted by 
visceral organs have been identified. . . 
The hepatotrophic effects of infused insulin were. inter-
preted at first in terms of relief of the relative insuhnoprival 
state caused by the portal diversion. this view was revised in 
1979 when it was shown with the Eck fistula assay that HSS 
had hepatotrophic effects indistinguishable from insulin24 
Because HSS activity was not species-restricted,8,25 and was so 
precisely measurabie, increasingly purified rat HSS could be 
identified with certainty with a single canine Eck fistula 
experiment.8,25-27 Eventually, the peptide purified from HSS 
was renamed augmenter oJ liver regeneration (ALR)8 and 
cloned.28 ,29 The cDNA for rat ALR encodes a protein contain-
ing'198 amino acid residues and has a molecular weight of 
about 22 kd. 29 ,30 Cloned mouse and human ALR genes30 that 
have highly conserved nucleotide and predicted amino acid 
sequences have been mapped to allele-rich regions of mouse 
chromosome 17 and human chromosome 16.30 
Meanwhile, the six additional molecules annotated in 
Table 16-9.12,14,15,23-45 also had been shown to have priming-
dependent hepatotrophic qualities comparable with insulin 
and ALR. Unlike insulin and ALR, two of these molecules 
(hepatocyte growth factor [HGFj and transforming growth 
factor [TGF-a]) initiate mitosis of cultured hepatocytes. Like 
an the others, however, they are only feebly mitogenic when 
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injected into unaltered animals 9 ,12 The small number of 
molecules with genuine hepatotrophic qualities CTable 1) as 
established by the criteria of the Eck fistula, minimum 
hepatectomy, or both assays, contrasts with the large number 
of physical and chemical factors that can initiate mitosis of 
hepatocytes in vitro or in viVO. lO,ll,46-49 
Epidermal growth factor does not fulfill hepatotrophic 
criteria even though it is mitogenic for cultured hepatocytes, 
has a 30% homology with the hepatotrophic TGF-a, and has 
the same receptorlO,ll Moreover, the historical contention 
that glucagon augments the growth effects of insulin and is, 
therefore, itself hepatotrophic50,51 is not consistent with the 
results of either the Eck fistula 14,15,32 or minimum hepatec-
tomy assay9 The degree of congruence of the two assays also 
is evident by their parallel identification of the only two 
molecules known to have highly specific antihepatotrophic 
effects: TGF-_fj32,36,52-54 and rapamycin (Table 1).55 
The essentially identical hepatotrophic properties of the 
eight disparate molecules shown in Table 1 has suggested the 
possibility that one of them could be an initiator of, target of, 
or interacter with all the others. ALR has been a candidate for 
such a keystone role, in part because it is heavily expressed in 
the liver, more so than in any other tissue ororgan, excepting 
only the testis.2s,3o Unlike the other hepatotrophic and 
antihepatotrophic agents, however, the paucity of informa-
tion about ALR under normal or altered conditions, including 
even the location of its synthesis in the liver or its kinetics, 
has hindered evaluation onts physiological Significance. 
Consequently, we have determined the localization and 
cOncentration of ALR and of ALR mRNA in adult, weanling, 
and posthepatectomy livers and of hepatocytes in culture, as 
well as the concentration of circulating ALR following panial 
hepatectomy. The unexpected results reported here mandate 
revision of previous assumptions about the metabolism of 
ALR and its potential role in the homeostasis of the liver or 
other tissues. 
TABLE 1. Growth Factors Revealed by In Vivo Studies 
Growth Factors 
Hepatotrophic 
Hormones 
Insulin 
Growth factors 
HSS or ALR 
IGF-II . 
TGF-Ct* 
HGF* . 
Immunosuppressants 
C yclosporine . 
FK506 
Immunophilins 
FKBP12 
Antihepatotrophic 
Growth factors 
TGF-pt 
Immunosuppressants 
Rapamycln t 
Endogenous Origin 
Pancreas (B cells) 
Ubiquitous; regenerating or hyperplastic livers (previous view) (6,7,24,25) 
Ubiquitous; liver Kupffer endothelial and stellate cells (31) 
Ubiquitous; liver Kupffer cells (33); stellate cells (34) hepatocytes (34, 35) 
Ubiquitous; liver stellate cells (37) and liver matrix (38-40) 
NA 
Ubiquitous 
Ubiquitous NPC 
NA 
Abbreviations: NA, not applicable (xenobiotic); ND, not done. 
*Mitogenic in tissue culture. 
tlnhibitory in tissue culture. 
<"D~1inimum 
Hepatectomy 
Eck's Fistula (or other) 
Assay In Vivo Assay 
14,15 23 
24,25,28 6-8,25-27 
32 ND 
32,36 9,12 
32,36 9,12 
41 42 
43 44 
45 ND 
32,36 54 
55 55 
'I 
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MATERIALS AND METHODS 
The protocols of this investigation were approved by the IACUC, 
University of Pittsburgh, and the Veterans Administration MediCal 
Center in accordance with the NIH gutdelines. 
Preparation of oecombina~t RC!t ALR. Rat ALR cDNA-transfected 
b~cherichia coli were grown in a medium containing 1% tryptone, 
0.5% yeast extract, 0.5% NaCl, and 100 ].lglmL ampicillin (pH 7.2) 
by overnight incubation in an agitator at 37°C. The cell;; were 
washed, suspended in 10 mmoVL sodium phosphate (pH 8.0) 
containing 0.15 moVL sodlum chlOride, and digested with (0.5 
rilglmL) lysozyme (crystallited from chicken egg white; Sigma 
Chemical Co., St. Louis, MO) for 30 minutes in room temperature. 
The digested material was sonicated for 20 minutes in an ice bath 
(IS-second bursts with IS-second intervals), centrifuged (12,500g 
for 20 minutes at 4°C), and the supernatant mixed with sodium 
acetate (final concentration, 100 mmoVL). ALR wJ-s then extracted 
by sequential acid treatment and ethanol precipit~tionK 8 For purifica-" 
tion of Ail~I the ethanol pellet was dissolved in 2S. mmoVL sodium 
a~etate (pH 4.65) containing 50 mmoVL NaCl. The solution was 
concentrated using a YCQ5 Amicon Diaflo membrane in an ultrafil-
tration cell (AmicoIi Corp., Danvers, MA) at 4°C under nitrogen, 
fiitered through a 0.2-].lm cellulose acetate membrane (Gelman 
Cor:p., Ann Arbor, MI), and loaded on a SP 26/10 cation exchange 
column in an automated fast-protein liquid chromatography system 
(Pharmacia Biotechnology Corp., Piscataway, NJ). A linear gradient 
oJ 0 to 1,000 mmoVL NaCl was applied at a flow rate of 4 mUmin. 
As determined by enzyme-linked immunosorbent assay (ELISA), 
fractions eluting between 600 and 800 mmoVL NaCl contained ALR, 
which were combined and dialyzed twice against 50 mmoVL NaCl iii 
20 mmoVL Tris (pH 7.4) using a 1,000-mw cut-off SpectraPor6 
dialysis tubing (Spectrum Industries, Houston, TX) . For furtiler 
p4rificatioIi by FPLC; the concentrated material, was.loaded on a 
FF-Q column, and a liriear gradient of 0 to 1,000 mmoVL NaCl rvas 
applied at a flow rate of 4 mUmin. Fractions containing ALR 
(material eluting between 2S0 and 325 mmoVL NaCl) were com-
bined, concentrated by YC05 ultrafiltration,reconstituted in 20 
mmoVL Tris-HCI (pH 7.4) containing 5QmmoVL NaCI at 1 mg of 
protein per milliliter, and stored in aliquots at -TM~CK 
Preparation of Antibodies for ALR. p~ndaDrd methodology Was em-
ployed for the development of antibodies against rat recombinant 
ALR (rrALR) and its peptide fraginents (Covance, Inc., Denver, PA). 
Briefly, white New Zealand female rabbits (approximately 3 kg) were 
ptebled and immunized with intradermal injections of the adjuvant. 
Three weeks after the initial immunization and every 3 weeks 
thereafter, mixtures of the conjugates of keyhole limpet hemocyanin 
with ri-ALR (250 ].lg) or its peptide fragments (250 pg)in phosphate-
buffered saline (PBS) were injected subcutaneously at multiple sites. 
Ten to 12 days after each immunization, approximately 20 niL blood 
Was drawn, and serum was separated by centrifugation. 
For isolation of the IgG fraction, the serum Was diluted with 10 
volumes of 10 mmoVL sodium borate (pH 8.0) and loaded -on a 
Protein A column (Pharmacia Biotechnology) equiltbratecl in the 
same buffer. The column was washed until the absorbance of the 
eluted fractions at 280 nni was similar to ·that of the borate buffer, 
and· the IgG was eluted with Pierce gentle elution buffer. (Pierce 
Chemical Co. Rockford, IL). Fractions with absorbance grea~er than 
0.05 as compared With the elution buffer were pooled arid dialyzed 
against two· changes of Tris-buffered salirie buffer_ in a l;OOO-mw 
cut~off SpectraPor6 dialysis tubing (Specirum Industries). 
Western Analysis of ALR in Hepatic Extracts and Reco.tnbinant ProtlCin 
Native ALR was extracted frorn the liver and hepatocytes by 
homogenization in 100 mmoiIL sodiuin acetate (pH 4.6?).8After 
centrifugation. pH of the supernatant was neutralized, and solution 
containing 200 j.lg protein (towry's procedure) was loaded on a 15% 
sodium dodecyl sulfate (SDS)-polyacrylamidegeL After electropho-
. resis, the separated proteins were transferred to a .lmm.obilon"P 
transfer paper (Millipore, Bedford, MA), and nOIispecific sHes were 
blocked with 1% nonfat milk in PBS (blocking buffer). The paper 
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was washed in PBS and incubated with anti-rrAtR antibody (2 
].lglmL) in blocking buffer, followed by washing and incubation with 
donkey anti-rabbit horseradish peroxidase conjugate EAmersh~mI 
Arlington Heights, IL). The ALR-anti-ALR complex was detected 
using an ECL kit (Amersham) and chemoliiminescence on Fuji 
X-ray filrn. . . . 
ALR ELISA. Immulon-l flat-bottom 96-well ELISA plates (Dyna-
tech Labs, Chantilly, VA) were coated with anti-rrALR antibody (1 
].lglwell) in 50 j.lL sample dilution buffer (0.1 moVL Na2C03 [pH 
9.0]) by overnight incubation at 4:0 c. The medium was removed and 
the plates washed (4x) With the wash buffer(20 mmoVL Tris [pH 
7.5] containing 0.5 moVL NaCl and 0.05% Tween OMF~ After 
blocking the nonspecificsit~ with "Super Block" (Pierce Chemical 
Co.),the plates were washed (4X) with the wash buffer. pample~ or 
standards dissolved in sample dilution buffer (20 minoVL Tris [pH 
7.5] containing 0.5 moliC NaCl: 0.05°4> Tween 20) and 1% "Sea 
Block" (Pierce Chemical Co.) were added to the wells, and the plates 
incubated at 4°C overnight. The plates were washed (6X), incu-
bated with hiotinylated anti-rrALR antibody (prepared using a kit 
from Vector Laboratories, Burlingame, CA) (0.2 ].lglwell in 100 j.lL 
sarnpledilution buffer) for 1 hour at room temperature, and washed 
(6X). The plates were iricubated with avidin alkaline phosphatase 
(Sigma Chemical Co.) (100 ].lUwell of 1:1,000; vollvol it1sa~ple 
dilution buffer) for 30 minut~ at Toom temperature. After washing 
(8X), incubation was performed in the dark With aikaline phosphac 
tase substrate (Sigma Chemical Co.) (1 mglmL in 0.1 mollL NaHC03 
containing 1 mmoVL MgCb; 100 mUwell), and the developed color 
was read in a microplate spectrophotometer at 40S nm. . 
A linear relationship was observed between ALR concentrations 
of 3 to 500 pg and corresponding absorbance of the developed color 
(Fig. lA). The selectivity of the assay for ALR was _demonStrated by 
-the lack of reactivity at concentrations in the micromolar f~nge of 
several other proteins including albumin, glucagon; insulin, angio-
tensin, insulin-like growth factor-II, and HGF (results not shown). 
Determination of ALR in Serum and Liver Tissue After Partied Hepatec-
tomy. Partial hepatectomy (40% or 700k) was performed in rats 
(male Lewj.s 200-250 g; Harlan Sprague-Dawley, Indiariapolis, IN) as 
described previo'usly.2,26 At indicated times after the surgery, blood 
was drawn via the abdominal aorta, and serum separated by 
centrifugation. The liver was excised and snap-frozen in liqUid 
nitrogen. Liyers and blood from sham-operated rats were used as 
controi. Serum was dihited with the sample dilution. buffer (1:1, 
volivol), and 100-].lL aliquots were used for the ELISA. The liver (1 
g) Was hombgenized in ice-cold 100 mmoVL .sodium acetate (pH 
4.65), and the homogenate was centrifuged at 20,190g. for 1 hour at 
4"C after dilution to 50 mL. The supernatant was further diluted 
with sample dilution buffer (1:16; vollvol), and 100-].lL aliquots 
were used in the ELISA. 
Preparation of Hepatocytes. Hepatocytes were prepared from male 
Sprague-Dawley rats (180-250g; Zivic-Miller, Zelienople, PA) by 
collagenase digestion of the liver .as described previously.56 The 
Viability of the cells was determined by Trypan blue exclusion, and 
preparations with viability greater than 85% or higher were used. 
The cells were suspended in Williams' medium E containing 10% 
feral cillf serum, 2 mmolf[ L-glutamine, and 7 mgIL insulin (Eli Lilly 
Co., Indianapolis, IN) at 0.5 X 106 per milliliter. Aliquots of the cell 
suspension (2 rnl/well) were plac~d in S-wel~ plates. The.medium 
was renewed after 3 hours, and cells were used the following d~yK 
Preparation ofNortparenchymal Ceils. Ndnparenchymal cells. (NPCs) 
were prepar~d by collagenase and protease digest19n of the liver, and 
cultured as described pi:eviously.57-59 Stellate cells were separated 
ftom the other NPCs by centrifugation on a Nycodenz gradient.58 
Kupffer celis and endothelial cells were separated on a metrizamide 
gradient, followed by centrifugai elutriat~onv Freshly isolated cells 
were assessed for Viability (whichwas always greater than 95%) with 
Trypan blue, and were useq. as such for eXtraction and analysis of 
ALR by ELISA. The purity of stelijlte !=ells was determine~ bls 
vitamin A autofluorescence and immunolabeling for desmm. 
Antibodies to intracellular adhesion molecule-l (clone lA29; Phar-
B 
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FIG. 1. ALR ELISA. (A) Indicated concentrations of rrALR were used to 
develop a standard curV\! as des<.:ribed in Materials and Methods. Each value 
represents average of duplicate determinations. (B) One hundred. microliters 
of the rat serum was spiked with indicated concentrations of rrALR. For 
control, the saIlle concentrations of ALR were mixed With 100 JIl PBS. ELISA 
was then performed as described in Materials and Methods. Valves represent 
averages of duplicate determinations qf the experiment performed at least 
three times with essentially similar results. 
Mingen, San Diego, CA)60 and ED-l (clone IC7; PharMingen)6! 
were used to determine the purity of endothelial cells and Kupffer 
cells, respectively. By these procedures, the individual NPC prepara-
tions were f01 .. 1Ud to be more than 95% pure. 
Determination of ALR in Freshly Isolated and Cultured Cells. Freshly 
isolated hepatocytes, stellate tells, Kupffer cells, and endothelial 
cells were homogenized in 100 mmollL sodium <J.cetate (pH 4.65). 
After centrifugation at 13,OOOg for 1 hour at 4°C, the supernatant 
was used for determination of ALR by ELISA. 
After an overnight incubation <It 37°C in <l humidified atmosphere 
containing 5% CO/95% aiT, cultured. hepatocytes, stellate cells, 
Kupffer cells, and endothelial cells Were washed, treated with 
trypsin (0.05% ineanks~ balanced salt solution without MgH and 
Ca2+ and containing 0.5 mmol/L ethylene4iaminetetra<lcetic acid; 
GIBCO BRL, Gaithersburg,MD), \lnd suspended in ice-cold PBS. 
Cells were counted and the suspension was centrifuged at 1,000g for 
10 minutes at 4°C AL,R from the cell pdlet was extracted with 100 
mmol/L sodium acetate (pH 4.65) and determined by ELISA. . 
fmmunohistoc~emical Analysis of ALR in t~e Liver and Cultured Hepato-
cytes. A sllce of the left l'lteral lobe of the liver was embedded in 
O.CT. compound (Miles, Inc., Elkhart, IN) and frozen in liquid 
nitrogen. Sections (4-Jlm thickness) were cut, mounted em charged 
slides (Fisher Scientific, Pittsburgh, PA), and afr-dried overnight at 
room tempera,ture. Before immunostaining, sections were fixed in 
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ice-cold acetone for 10 minutes and air-dried. Hepatocytes were 
cultured in chamber slides (Nalge Nunc International Corp., Nape-
ville, IL), and after overnight incubation, they were washed twice 
with PBS and fixed in absolute ethanol for 10 minutes at room 
temperature. Imrnunostaining of both liver sections and cultured 
hepatocytes was performed as described previously62 using anti-
rrALR antibody. Rabbit IgG was used as an isotype control. 
Determination of ALR mRNA by Reverse-Transcriptase Polymerase Chain 
Re(lction. The relative levels of the ALR and IX-actin cDNAs were 
assessed by semiquantitative reverse-transcriptase polymerase chain 
reaction CRT-PCR) as desqibed by Dallman et al.63 This technique 
was selected because of its ease and reproducibility in quantifying 
mRNA as compared with other methods such as Northern blotting, 
primer extension, and nuclease protection assays63.64 The level of 
[3-actin mRNA was measured to determine the efficiency of cDNA 
synthesis and reverse transcription of different batches of mRNA. 
The PCR reactions were performed for 15,20, 25,30, and 35 cycles 
to quantify the product in the linear phase. The PCR primers specific 
for the rat ALR cD)JA were 5'CGGACCCAGCAGAAGCGGGAC3' 
and 5'TTAGTCACAGGAGCCGTCCTT3' ,28)0 and for [3-actin cDNA, 
they were 5 'TTCTA CAA TGAGCTGCGTGTG3' and 5 'TTCATGGAT-
GCCACAGGATTC3'. Details of the procedure are described else-
where.58 . 
[125I} ALR Binding to Cultured Hepatoeytes. rrALR was radioiodinated 
by a lactoperoxidase procedure,55 and its purity was determined by 
fast-protein liql,lid chromatography (see above) and SDS-polyacryl-
amide gel electrophoresis, By both procedures, radiolabeled rrALR 
was found to migrate as a single band. Specific activities of 
radioiodinated ALR preparations were between 750 <lnd 900 CiJ 
mmo!. For the bindIng assay, the cells were washed three times with 
ijanks' balanced sal~ solution containing 10 mmollL HEPES (pH 
7.4) and 0 1 % bovine serum albumin, and placed in this medium 
cont<J.ining 0.3 mg/mL bacitracin (a blocker of internalization of 
pep tides and proteins66) and 20 pmol/L [1251J rrALR + molar excess 
(100 nmol/L) of unlabeled rrALR. The reaction was terminated after 
a 3-hour incubation at room temperature by aspirating the inedium, 
followed by four washes with Hanks' balanced salt solution/bovine 
serum albumin. Cells were digested with 0.75 N NaOH, and 
radioactivity in the digests was determined in a gamma-col,lnter. 
Specific binding of [125I1ALR was ca1culateq as the difference 
between cell-associated radioactivity in the presence and absence of 
unlabeled ALR. 
RESULTS 
Semm and Hepatic Levels of ALR (With ELISA) 
Unaltered Animals. Serum samples from unaltered adult rats 
contained readily measurable amounts of nati.ual ALR (Fig. 
IB). When the samples were spiked with predetermined 
concentrations of ALR, theintensity of the developed color 
increased proportionately (Ftg. IB), indicating the reliability 
and the sensitivity of the assay 
Becat,lse the finding of ALR in the control serum (see Fig. 
IB, qnd time "0" in Fig. 2) and liver (Fig. 2) of adult rats was 
inconsistent with previous assumptions (based on bioassay) 
that ALR was present in weanling but not in adult livers, we 
compared the concentration of ALRin the two age-defined 
categories. With the ELISA determinations, the ALR concen-
trations in the livers and sera were essentially the same in 
both (Table 2). 
After 70% Hepatectomy. Serum ALR concentration rose 
steadily for 12 hours, and declined in. the ensuing 12 hours to 
near~basal concentrations (Fig. 2A). Serial ALR concentration 
in the residual liver fragment showed an inverse pattern. ALR 
declined for the first 12 hours following hepatectomy, and 
then gradually tended to return to the near-basal level by 40 
hours (Fig. 2B). 
( 
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FIG. 2. Serum (A) and hepatic (B) ALR levels following partial hepatec-
tomy. Following 40% or 70% hepatectomy, the rats were killed at indicated 
times. Serum and the liver samples were processed for determination of ALR 
by ELISA as described in Materials and Methods. Each value represents the 
average of triplicate determinations ± SO from a representative experiment 
repeated two or three times. 
After 40% Hepatectomy. In contrast, hepatic ALR levels did 
not change significantly after 40% hepatectomy (Fig. 2B), and 
the elevations of serum levels of ALR were smaller than after 
70% hepatectomy. The peak of the rise occurred at 6 hours, 
and the concentration returned to basal levels at 12 hours 
(Fig.2A). 
Determination ALR by Western Analysis 
In Extracts of Whole Liver. The results were congruent with 
the findings with ELISA (see above) in that the levels of the 
three immunoreactive proteins with approximate molecular 
weights of 36, 38, and 40 kd were very similar in the extracts 
from the weanling and adult livers (Fig. 3). Consiqering the 
TABLE 2. Concentration of ALR in the Serum and Liver 
of Adult and Weanling Rats 
Adult rat 
Weanling rat 
Liver 
(pglmg wet weight) 
3710 ± 810 
3410 ± S60 
Serum 
(pglmL) 
280 ± 70 
210 ± SS 
NOTE. Blood of adult (1S0-200 g) and weanling (40-S0 g) rats was drawn 
via the abdominal aorta, after which the livers were excised, rinsed in 
ice-cold PBS, and snap-frozen in liqUid nitrogen. Concentrations of ALR in 
the liver and the serum were determined py ELISA. For details, see Materials 
and Methods. 
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multiple protein species reacting with the ALR antibodies 
(Fig. 3), it appears that ALR may exist as a dimer or even a 
multimer, as suggested previously.28.30 It should be noted that 
the 36-, 38-, and 40-kd proteins also exhibited immunoreac-
tivity for the antibody developed against the C-terminus 
sequence of rrALR (CSRVDERWRDGWKDGS) and against 
MRTQQKRDIKFRED (amino acid residues 74-87) (results 
not shown). 
In Extracts of Cell Populations. To determine which cell 
type(s) contained ALR, Western analysis was performed 
using protein extracts from freshly isolated hepatocytes and 
NPCs. All three anti-rrALR antibody-positive proteins found 
in the extracts of whole liver were also present in the extracts 
prepared from freshly isolated hepatocytes (Fig. 3); none 
were found in the eqUivalent amounts of extracts prepared 
from the NPCs (results not shown). Importantly, concentra-
tions of the proteins reacting with the anti-rrALR antibody 
were higher in extracts prepared from isolated hepatocytes 
than in extracts prepared from the whole liver. The pOSSibility 
that the lower concentrations of ALR in the whole liver 
together with the extracts from isolated hepatocytes resulted 
in part from dilution by extraparenchymal proteins was 
confirmed by the studies of ALR in intact livers (see below). 
Immunohistochemical Determination of ALR 
In Intact Livers. In sections of both the weanling and adult 
livers, the major immunoreactivity for ALR detected with the 
116-
97 -
66 -
45 -
29 -
H w A 
FIG. 3. Western analysis of ALR in hepatocyte and the livers of weanling 
and adult rats. Extracts of the livers and hepatocytes were mixed with 2X 
loading buffer O.12S moVL Tris-HCI (pH 6.8) containing 4% 50S, 20% 
glycerol, 5 mmoVL ethylenediaminetetraacetic acid, and O.OS% bromophe-
nol blue (1:1; voVvol), heated in a boiling water bath for 10 minutes, and 
proteins separated by electrophoresis on a lS% 50S-polyacrylamide gel. The 
proteins were transferred to the Immobilon-P transfer paper and immunola-
beled with anti-rrALR antibody. Oetails are described in Materials and 
Methods. H, hepatocytes from adult rats; W, weanling rat liver; A, adult rat liver. 
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anti-n ALR was in rh cyil~ol of parenchymal cells (Fig 4A 
and 4B) 'p es in the sections of liver tissue also were found 
to imrnunostam with anti-rrALR antibody, but variably and to 
a I ~Rer degree ( Fig. 4B, inse t). The immunostaining of the 
NPCs was not an artifact of the techmque, because no labeling 
was appar ' 11[ when isotype serum was used (Fig. 4A, inset). 
III Isolated Cell PopulCitlons. ALR was a prominent constitu-
ent of the cytosol of cultured hepatocytes (Fig. 4C and 4D) 
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Although freshl y iso la ted s tella te celis, Kupffer cells, and 
hepatic endothelial cells ( in hat order of frequency) also 
were found to con ta in ALR, the concentrations were much 
lower than those d te ted in hepatocytes (Table 3) Further-
more, on day 2 of culture , ALR could no t be detected in any 
NP Cs (Table 3) 
To confirm that hepa tocytes are capable of seueting ALR, 
we determined with Ell A the levels of the protein in the culture 
F[G . 4 100munohistochemical lo· 
calization of ALR in the livers of 
weanling and adult rats , and cui· 
tured hepatoc ytes. (A) \Vea nling ra t 
li ver' OCT-frozen liver sections were 
prepa red and immunolabeling was 
performed as described in Mate ria ls 
and Methods. The majority of hepa-
tocy tes exh ibiting immunolabeling 
fo r AIR can be ,ccn (or iginal magni-
fi catio n X 100) Inset: lsolype con-
trol with ra bbi : 19G showing lack of 
any positi ve staining (original mag-
nification X 1,000) (B) Adu lt rat 
live r: the major ity of hepalOcytes are 
positive for ALR. [n , et: lmmunostain-
ing (arrows) corresponding to the 
localizatio n of nonparenchyma l cells 
can be seen (original magn ifi catio n 
X l ,OOO). Cultured hepatocytts : (e) 
(All of the hepatocytes are pOSitive 
for ALR immunos tain (original mag-
nificatio n X 100) (D) HepatOcytes 
are seen to exhibit cytosolic localiza-
tion of AI.R immunostain; a bi-
nuclear cell is also show n (original 
magnifica lion Xl ,000) . Inset: Iso-
type control with rabbit IgG show-
ing lack of any positive staining 
HEPATOLOGY Vol. 29, No.5, 1999 
TABLE 3. Concentration of ALR in Freshly Isolated 
and Cultured Hepatic Cells 
ALR Concentration Cpgl104 cells) 
Freshly 
Isolated Cultured 
Hepatocytes 800:+:: 130 600 :+:: 150 
Stellate cells 8:+::3 Undetectable 
Kupffer cells 3 :+:: 0.5 Undetectable 
Endothelial cells 1 :+:: 0.5 Undetectable 
NOTE. Hepatocytes, stellate cells, Kupffer cells, and endothelial cells were 
prepared, counted, and a portion was snap-frozen in liquid nitrogen and 
stored at -70°e. The rest of the cells were placed in culture. The culture 
medium was renewed after allOwing the cells to attach (3-6 hours). After 
overnight incubation, the cells were detached from the plates by trypsin 
treatment and suspended in ice-cold PBS. A portion of the suspension was 
used for counting, and the rest was centrifuged at 1,000g for 10 minutes at 
4°C. ALR was extracted from the pelle ted cultured cells and freshly isolated 
(snap-frozen) cells, and analyzed by ELISA. Values shown are averages:+:: SD 
of triplicate determinations from an experiment repeated three times. 
medium of hepatocytes at various times up to 24 hours. As 
shown in Fi.g. 5, hepatocytes were found to secrete ALR into 
the medium in a time-dependent manner. At the end of the 
experiment, cellular damage was assessed by Trypan blue 
staining and the release of lactate dehydrogenase in the medium. 
More than 95% of cells excluded the stain, and the release of 
lactate dehydrogenase was not Significant during the entire 
time course, indicating that the accumulation of ALR in the 
medium was not caused by its leakage from the cells. 
Expression of ALR mRNA in the Liver and Hepatocytes 
The foregoing results suggested that hepatocytes are the 
primary sites of ALR synthesis in whole weanling and resting 
adult livers, as well as in cultured hepatocytes. To confirm 
this, ALR mRNA was determined in all three kinds of 
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FIG. 5. Time course of the release of ALR into the culture medium of 
hepatocytes. Hepatocytes were isolated and cultured as described in Materi-
als and Methods. After 3 hours, the medium was renewed, and serum-free 
condition was introduced following an overnight incubation. At indicated 
time pOints, the medium was aspirated and ALR levels were determined by 
ELISA. Values are means:+:: SD of triplicate determinations of a representative 
experiment repeated three times with essentially similar results. 
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specimens using a semiquantitative RT-PCR procedure. SimI-
lar amounts of PCR products were generated from ALR 
messages present in the livers of weanling and adult rats, and 
from freshly isolated hepatocytes as shown from a representa-
tive experiment in Fig. 6. When the resolved PCR products 
were hybridized with radio labeled probes after Southern 
transfer (Fig. 6A) and the net radioactivity of each band was 
determined, the ratio of the radioactivity generated from 
radiolabeling of ALR and [3 actin mRNAs also was similar in 
the three kinds of specimens (Fig. 6B). These results clearly 
demonstrated a similar extent of ALR mRNA expression in 
the adult and weanling rat livers, and in isolated hepatocytes. 
Hepatic ALR mRNA was determined after partial hepatec-
tomy to ascertain changes in its expression after partial 
hepatectomy. No Significant alteration in ALR mRNA concen-
tration was observed at any time up to 40 hours following 
40% or 70% hepatectomy (results not shown). 
Binding of Radiolabeled ALR to Hepatic Membranes 
and Cultured Hepatocytes 
The inability of ALR to exert a mitogenic effect on 
hepatocytes in vitro, even in the presence of other mitogenic 
agents,S has been interpreted to mean that hepatocytes do 
not contain receptors for ALR. Consistent with this possibil-
ity, a competition binding assay using radioiodinated rrALR 
A 
15 20 25 30 35 Cycles 
P Actin 
ALR 
WAH WAH WAHWAH WAH 
8 
0.0 0.5 1.0 1.5 
Weanling Liver 
Adult Liver 
Hepatocyte 
t:=======::::::::::~-~ 
ALRIP Actin ratio 
FIG. 6. Analysis of ALR mRNA expression by RT-PCR. The extent of the 
expression of ALR and i3 actin mRNAs in the livers of weanling and adult 
rats, and hepatocytes was determined by RT-PCR as described in Materials 
and Methods. (A) Southern blot of the PCR products generated after is, 20, 
25, 30, and 35 cycles from equal amounts of cDNAs derived from the livers 
and hepatocytes were resolved in a 1.2% agarose gel, then transferred to 
Nylon membrane. The blot was hybridized with radiolabeled DNA probes 
specific for ALR and i3 actin. (B) The ratio of radioactivity associated with the 
PCR products generated from ALR and i3 actin cDNAs of the same samples. 
The results shown are representative of an experiment repeated three times. 
W, weanling rat liver; A, adult rat liver; H, hepatocytes from adult rats. 
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FIG. 7. Binding of ALR to cultured hepatocytes. Hepatocytes were 
isolated and cultured as described After an overnight incubation, cells were 
washed and [125IJALR binding assay was performed before and after 
treatment of cells with acidic medium. Results are averages ± SD of triplicate 
determinations of an experiment that was performed at least 5 times. Total 
and nonspecific eNS) binding of radioiodinated ALR is shown. For details, 
see Materials and Methods. 
failed to show specific binding of ALR in the hepatocytes 
(Fig. 7). 
However, because cultured hepatocytes synthesize and 
secrete ALR, the possibility remained that ALR receptors on 
the hepatocytes were down-regulated. Therefore, we treated 
cultured hepatocytes with acidic medium,56 a procedure 
known to dissociate bound peptide ligand from its recep-
tors.56.67 Although this treatment improved nonspecific bind-
ing, it did not unmask specific binding of ALR (Fig. 7). 
DISCUSSION 
The current investigations were facilitated by the develop-
ment of a sensitive ELISA that, combined with mRNA and 
other determinations, yielded new information about the 
synthesis and localization of ALR. Contrary to expectations, 
the findings were essentially the same in resting adult livers 
and in weanling livers. Conceivably, the ALR in the quiescent 
adult livers has different physiological properties than the 
ALR in proliferating (Le., weanling or posthepatectomy) 
livers. At present, however, a more likely explanation for the 
historical inability to demonstrate HSS in adult rat liver 
cytosol (see Introduction) may be the presence of an inhibi-
tor, as was originally suggested by LaBrecque and Pesch.6 
This hypothesis has gained credibility with the discovery of 
qdc_~flI1lISU and other members of the qdc-~ superfamily 
(e.g., activin69). 
In both the intact adult and weanling livers, as well as in 
freshly isolated cell subpopulations, the principal concentra-
tion of ALR peptide and essentially all of the mRNA tran-
scripts were in hepatocytes, similar to TGF_a34,35 but unlike 
the hepatotrophic HGf37 and antihepatotrophic qdc_~4SI4T 
that are syntheSized by NPCs (Table 1). ALR also was found 
by immunolabeling in the NPCs of the intact livers, but the 
peptide was irregularly distributed and of lower concentra-
tion than in hepatocytes. When the isolated NPCs were 
cultured, all of the ALR initially found in them disappeared 
within 24 hours, In contrast, cultured hepatocytes had no 
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loss of immunolabeling and actually secreted the ALR into 
the medium in a time-dependent manner. 
ALR receptors could not be demonstrated either on the 
cultured parenchymal cells or on the NPCs. However, be-
cause of the entry of ALR into the NPCs, it remains possible 
that ALR affects hepatocytes indirectly via NPCs whose ALR 
receptors were down-regulated and therefore not demon-
strable under the conditions of the in vitro experiments; this 
has been observed with other growth factors. 68 ,70 Another 
possibility is that the ALR molecule was inappropriately 
labeled for binding. 
A further unexpected finding was the progressive decrease 
in the concentration of hepatic ALR after 70% hepatectomy in 
adult rats. This began to decline within 30 minutes, reached 
an estimated nadir of about two-thirds control concentration 
after 12 hours, and then returned toward, but not to, control 
levels in the ensuing 12 hours. The depletion was so much 
less marked with 40% hepatectomy that it could not be 
demonstrated, and therefore could only be assumed, As 
previously noted by Giorda et apo in mouse hepatectomy 
experiments, there was no change in our current rat studies 
in the quantity of the ALR mRNA transcript after either 70% 
or 40% hepatectomy. Interestingly, it has been suggested 
recently that HGF also is not synthesized during regenera-
tion, but is released at the time of regeneration from storage 
in intracellular matrix.38-4o 
Corresponding temporally to the decrease in hepatic ALR, 
the concentrations of circulating ALR followed an opposite 
pattern by rising 10-fold over the first 12 hours from the low 
concentrations consistently found in the control sera. These 
then returned to nearly control levels by 24 hours, the time 
when peak regeneration in the rat is known to occur. 11,68,7l 
The increases in circulating ALR were commensurately less 
and of shorter duration with 40% hepatectomy. Thus, the 
release of stored ALR from hepatocytes, rather than acceler-
ated synthesis as previously assumed, probably accounts for 
most if not all of the posthepatectomy increase in the 
circulating peptide. It may be Significant that the changes in 
both the liver tissue and blood are already detectable within 
30 to 60 minutes, earlier than TGF-a and at least as soon as 
HGPO,ll 
The foregoing results have further established the associa-
tion of ALR with liver regeneration, but they do not clarify its 
homeostatic role. Nor is the phYSiological role known of most 
of the other endogenous hepatotrophic molecules shown in 
Table 1, none of which (including HGF and TGF-a) substan-
tially affect the liver in vivo unless the liver already is primed. 
The requirement of priming for demonstration of the growth 
effects of the hepatotrophic agents has increasingly raised the 
possibility that the initiation of mitosis by a wide range of 
nonspecific causes and the escalation of this early response to 
regeneration involve separate and distinct mechanisms.8,10,32,72-74 
In addition, it may be prudent to reserve judgment about 
the relative physiological significance of either primary or 
augmenting mitogens. Although HGF and TGF-a (plus 
epidermal growth factor) are usually considered to be the 
principal liver growth factors,lO,ll this conclusion has been 
supported largely with evidence from circumstances that 
exist only in artificial laboratory systems. In-contrast, insulin, 
which frequently is described as "permissive" of regeneration, 
has been shown with a panoply of physiological evidence not 
remotely approached with any other molecule to play an 
indispensable role in liver growth and regeneration22,23 and to 
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have molecular biological mechanisms remarkably attuned to 
cellular growth controp6,77 
Furthermore, Steiner78 proposed a context of regeneration 
more than 20 years ago based on experiments with insulin in 
which mechanisms of signalling were described not only for 
more cells to maintain the appropriate liverlbody weight 
ratio, but also for efficient removal of superfluous cells by 
apoptosis (see also discussion of article by H.K. Weinbren). 
The interaction and versatility of these mechanisms in 
regeneration have been recently demonstrated by Sakamoto 
and Demetris el al.,19 who showed how a reduction in the rate 
of programmed cell death allowed nearly normal liver regen-
eration in rats despite a loss of efficient mitotic signalling in 
interleukin-6-deficient rats. 
The implication of such observations is that the context 
developed for research in liver regeneration during the last 
two decades may need major correction. In 1995, the series of 
reviews on this subject was introduced with the opinion that 
the liver does not exhibit true regeneration (i.e., that exhib-
ited by amphibians), but rather undergoes compensatory 
hyperplasia to establish the optimal mass for body sizeso 
From this perspective, it would be logical to view the process 
of regeneration as a "cascade" into which newly discovered 
growth and antigrowth molecules could be neatly fit. Instead, 
we envision liver regeneration as a genuine recapitulation of 
the organogenesis of otogeny in which the appearance, 
proliferation, and disappearance of cells is governed by 
mesenchymal/epithelial molecular signalling. 30 
It remains puzzling that the diverse hepatotrophic mol-
ecules all appear to have the same effects on the primed liver. 
This could be explained most readily if these effects were 
mediated by a molecule within the liver itself that serves as a 
"master switch." In view of its independence from an acute 
increase in syntheSiS and its consequent rapid response time, 
ALR might be a candidate, working through immunologic 
pathways. Vujanovic et al.81 recently reported that natural 
killer (NK) cells in the liver fragment left after 70% hepatec-
tomy (but not in peripheral lymphoid organs) underwent a 
sequential loss and then restoration of cytotoxic and cytolytiC 
function, while the susceptibility of hepatocytes to NK 
cell-induced lysis declined during the early phases of regen-
eration, with subsequent return to basal values. 
Such data suggested that NK cells may be involved not only 
in the termination of regeneration as previously proposed by 
Itoh et al.,82 but in its initiation.81 The hypothesis that NK 
cells may be regulated in turn by hepatotrophic factors81 has 
been tested in normal rats by administration for 24 hours of 
three hepatotrophic molecules: ALR, insulin-like growth 
factor-II, and HGf83 When given to the intact animal, each of 
these molecules mimicked the changes in NK cell function 
that occur after partial hepatectomy. In contrast, none had an 
effect when added individually or in combination to the 
media of cultured NK cells, demonstrating the apparent need 
for an additional as-yet-unknown intermediary mechanism of 
NK cell regulation. 
It is self-evident that all of the hepatotrophic and antihepa-
to trophic molecules listed in Table 1 can induce profound 
changes in the immune system, and that most of these 
molecules are primarily associated either with normal im-
mune function or its therapeutiC alteration: i.e., the three 
T-lymphocyte-directed immunosuppressants (cyclosporine, 
tacrolimus, rapamycin); three cytokines (HGF, TGF-a, TGF-
13); and a ubiqUitous immunophillin (FKBP12) to which 
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tacrolimus binds and which in turn binds84,85 to TGF-13 
family Type I receptors86 with inhibition of TGF-13 signalling 
pathways.87 Thus, it would be premature to conclude that 
regeneration is not a complex immunologic event of very 
early evolutionary development as we have suggested previ-
ously,30 or that ALR is not a combined immune- and 
growth-regulatory gene. 
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